减肥手术在患有晚期心力衰竭的患者中的作用
Darae Kim1, In-Cheol Kim2, Jong-Chan Youn3
1Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
概括
腹腔外科 (BaS) 有效地降低了晚期心力衰竭 (HF) 患者的BMI,提高了心脏移植资格,而不会影响存活率. 这项研究表明,BaS对这一群体是安全的.
科学领域:
- 心脏病学 心脏病学
- 腹部外科 腹部外科
- 移植 移植 移植 移植
背景情况:
- 肥胖是晚期心力衰竭 (HF) 患者的一个重大问题.
- 在这种高风险人群中,减肥手术 (BaS) 的安全性和有效性在很大程度上是未知的.
- 了解BaS结果对于优化高级HF治疗策略至关重要.
研究的目的:
- 评估经过BaS治疗的高级HF患者的临床发展轨迹.
- 为了比较高级HF患者与没有BaS的结果,专注于心脏替代疗法.
- 评估BaS对BMI降低,心脏移植资格和移植后存活率的影响.
主要方法:
- 对患有肥胖症 (BMI>35 kg/m2) 的高级HF患者进行了回顾性研究.
- 对比了15名BaS患者 (袖子胃切除术或胃绕道术) 和62名接受心脏移植 (OHT) 或机械支持的非BaS患者.
- 分析了BMI降低,OHT资格和OHT后的生存率.
主要成果:
- BaS导致BMI显著降低 (平均BMI从39.8下降到31.6公斤/米2).
- 没有死亡率与BaS相关.
- 在BaS和非BaS组之间,OHT后的存活率是可比的.
结论:
- 腹腔外科手术是一种安全和有效的干预措施,用于在先进的HF患者中降低BMI.
- BaS可能会提高心脏移植的资格.
- BaS不会影响移植后的结果.
相关概念视频
Heart Failure Drugs: β-Blockers
446
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
446
Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147
Cardiomyopathy V: Interprofessional Care
41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K


